Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.
Saved in:
| Title: | Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study. |
|---|---|
| Authors: | Zhai, Tianyue1 (AUTHOR), Mitamura, Takashi1 (AUTHOR) takami@huhp.hokudai.ac.jp, Wang, Lei2,3 (AUTHOR), Kubota, Shimpei I.4,5 (AUTHOR), Murakami, Masaaki4,5,6,7 (AUTHOR), Tanaka, Shinya2,3 (AUTHOR), Watari, Hidemichi1 (AUTHOR) |
| Source: | Cancer Medicine. Apr2023, Vol. 12 Issue 8, p9697-9708. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.5674 |
